Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast

Clinical trial NCT02993159 · COMPLETED

Trial details

NCT number: NCT02993159
Sponsor: Northwestern University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ductal Breast Carcinoma In Situ Estrogen Receptor Positive

Start date: 2017-05-31
Primary completion: 2021-03-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.